1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 16th December 2024 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

Long Covid research

Post and discuss Long Covid research papers (excluding psychosomatic research) here

Page 102 of 113
Sort By:
Title Start Date
Replies Views
Last Message ↑
  1. Nightsong

    Multi-method phenotyping of Long COVID patients using high-dimensional symptom data, 2024, Green et al

    Nightsong, Oct 3, 2024
    Replies:
    3
    Views:
    345
    rvallee
    Oct 4, 2024
  2. Nightsong

    A call from patient-researchers to advance research on long COVID, 2024, Fitzgerald et al

    Nightsong, Oct 3, 2024
    Replies:
    3
    Views:
    415
    rvallee
    Oct 4, 2024
  3. EndME

    Serotonin reduction in post-acute sequelae of viral infection, 2023, Wong, Cherry et al

    EndME, Oct 16, 2023 ... 2
    Replies:
    26
    Views:
    4,704
    SNT Gatchaman
    Oct 5, 2024
  4. forestglip

    Gastrointestinal manifestations of long COVID, 2024, King

    forestglip, Oct 5, 2024
    Replies:
    2
    Views:
    334
    rvallee
    Oct 5, 2024
  5. Mij

    Post-COVID-19 condition—Clinical phenotyping in practice, 2024, Karen Humkamp et al

    Mij, Oct 4, 2024
    Replies:
    2
    Views:
    345
    rvallee
    Oct 5, 2024
  6. SNT Gatchaman

    No reduced serum serotonin levels in patients with post-acute sequelae of COVID-19, 2024, Mathé et al.

    SNT Gatchaman, Oct 3, 2024
    Replies:
    5
    Views:
    870
    ME/CFS Skeptic
    Oct 6, 2024
  7. SNT Gatchaman

    Cell invasive amyloid assemblies from SARS-CoV-2 peptides can form multiple polymorphs with varying neurotoxicity, 2024, Sanislav, Annesley et al.

    SNT Gatchaman, Oct 4, 2024
    Replies:
    2
    Views:
    801
    SNT Gatchaman
    Oct 7, 2024
  8. Andy

    Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19, 2022, Charnley et al

    Andy, Jun 13, 2022
    Replies:
    3
    Views:
    776
    SNT Gatchaman
    Oct 7, 2024
  9. Kalliope

    Post-COVID-19 Condition Fatigue Outcomes Among Danish Residents, O´Regan et al, 2024

    Kalliope, Oct 7, 2024
    Replies:
    1
    Views:
    864
    Kalliope
    Oct 7, 2024
  10. SNT Gatchaman

    Quantitative susceptibility mapping at 7 Tesla in COVID-19: mechanistic and outcome associations, 2023, Rua et al.

    SNT Gatchaman, Nov 24, 2023
    Replies:
    6
    Views:
    1,695
    Nightsong
    Oct 8, 2024
  11. Mij

    Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations, 2024, Catarina Rua et al

    Mij, Oct 8, 2024
    Replies:
    1
    Views:
    254
    SNT Gatchaman
    Oct 8, 2024
  12. Dolphin

    Trial Report Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study, 2024, Swank

    Dolphin, Oct 9, 2024
    Replies:
    1
    Views:
    935
    Dolphin
    Oct 9, 2024
  13. Sparkly Unicorn

    Post COVID-19 syndrome among 5248 healthcare workers in England: longitudinal findings from NHS CHECK, 2024, Dempsey et al

    Sparkly Unicorn, Oct 3, 2024
    Replies:
    15
    Views:
    1,334
    rvallee
    Oct 9, 2024
  14. Mij

    COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type, 2024, James R. Hilser et al

    Mij, Oct 9, 2024
    Replies:
    0
    Views:
    898
    Mij
    Oct 9, 2024
  15. Jonathan Edwards

    Is joint hypermobility linked to self-reported non-recovery from COVID-19? Case–control evidence ... , 2024, Eccles et al

    Jonathan Edwards, Mar 20, 2024 ... 2
    Replies:
    34
    Views:
    3,927
    Jonathan Edwards
    Oct 11, 2024
  16. Andy

    Review A review of intravenous immunoglobulin in the treatment of neuroimmune conditions, acute COVID-19 infection, and [LC]... 2024 Melamed et al

    Andy, Oct 11, 2024
    Replies:
    0
    Views:
    911
    Andy
    Oct 11, 2024
  17. Dolphin

    Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent, 2024, Tesch

    Dolphin, Feb 11, 2024
    Replies:
    3
    Views:
    1,102
    Peter Trewhitt
    Oct 12, 2024
  18. Dolphin

    Trial Report Exploring the role of galectin-9 and artemin as biomarkers in long COVID with [CFS]: links to inflammation and cognitive function, 2024, Elahi et al

    Dolphin, Sep 5, 2024 ... 2
    Replies:
    20
    Views:
    1,664
    Lindberg
    Oct 12, 2024
  19. SNT Gatchaman

    Exploring common pathogenic association between [EBV] and [LC] by integrating RNA-Seq and molecular dynamics simulations, 2024, Kanwal+Zhang

    SNT Gatchaman, Oct 13, 2024
    Replies:
    1
    Views:
    559
    Hutan
    Oct 13, 2024
  20. SNT Gatchaman

    Macro- and Microstructural White Matter Differences in Neurologic Postacute Sequelae of SARS-CoV-2 Infection, 2024, O’Connor et al.

    SNT Gatchaman, Oct 11, 2024
    Replies:
    3
    Views:
    969
    SNT Gatchaman
    Oct 14, 2024
Showing threads 2,021 to 2,040 of 2,252

Thread Display Options

Loading...
Page 102 of 113